Uber’s roughly $15 billion takeover of Delivery Hero has won board backing, moving the deal closer to completion and potentially creating one of the world’s largest food-delivery platforms outside China.
Maggie Beer Holdings Posts $9.5M Loss After Website Migration
Maggie Beer Holdings reported a $9.53 million FY26 statutory loss after organic search traffic fell following a website migration at Hampers & Gifts Australia. Group sales were broadly unchanged, while the food products business recorded stronger sales. The company ended the financial year with $1.9 million in net cash.
Popular Reads
France Imposes New Fees on Shein and Temu Fast Fashion
France becomes the first EU country to fine fast-fashion retailers based on product range, adding pressure on Shein and Temu.
Eddy Groves-linked Imagine Strikes $250M Merger with Eden Academy
Imagine Education is expanding its childcare operations after agreeing to a $250 million merger with Eden Academy, highlighting the growing importance of scale in Australia’s early learning sector.
ASIC Ends Mineral Resources Probe with No Further Action Against Chris Ellison
Mineral Resources has confirmed ASIC has closed its investigation into the miner and managing director Chris Ellison, removing a major regulatory overhang for the company.
Pizza Hut Wants to Be Cool Again With a Yo-Chi Twist
Pizza Hut is revamping its Australian stores with a Yo-Chi-inspired look, betting that a more modern design can shake off its dated image and reconnect with younger customers.
More business News
Titomic Seeks $15M as Advanced Manufacturing Company Faces Softer Revenue
ASX-listed advanced manufacturing company Titomic is seeking $15 million in fresh capital as it works to scale its technology and commercial opportunities.
Judge May Grant Expert Access to Tesla’s Engineering Systems
Victoria’s government moves to scrap its independent infrastructure advisory body, sparking concerns over transparency and facing pushback from opposition parties.
Australian Drugmaker CSL Strikes Deal to Cut US Prices
Australian biotech company CSL has struck a deal with the Trump administration to lower medicine prices in America while expanding its US manufacturing footprint with a US$1.5 billion investment.